Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion
Status
Conditions
Treatments
Details and patient eligibility
About
Background: Humans naturally produce ketone bodies under daily living conditions. The main ketone bodies are two functioning acids, beta-hydroxybutyric acid (3-OHB) and acetoacetate, and the pH-neutral, but odorous, acetone. In the fed state, level of 3-OHB is suppressed to an almost unmeasurable level while, in the fasted state, it rises to 0.1-0.5 millimoles (mM). Main regulation of ketone synthesis is the abundance of sugars and resulting adaptations in insulin secretion. Thus, ketone bodies are formed when sugar is not readily available and insulin is suppressed. This picture is, to a certain degree, seen in acute inflammatory states and, indeed, during starvation, where level of 3-OHB increases to 5-8 mM.
Hypothesis:
- Ketone bodies changes the insulin sensitivity and substrate metabolism in human subjects
- Ketone bodies changes the GH signaling in muscle and adipose tissue
Aim: The investigators wish to provide knowledge on changes in metabolites and shift in signaling pathways and insulin sensitivity during GH infusion and concomitant ketone bodies infusion among healthy subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- healthy men
- written consent
- body mass index (BMI) 18.5 - 25
- age 20-50 years
Exclusion criteria
- any kind of disease
- regular medication
Trial design
Primary purpose
Allocation
Interventional model
Masking
10 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal